Will Trump’s 100% pharma tariff hit India’s $10.5 billion generic business? 1-year window explained
Published on: April 3, 2026, 11:24 a.m. | Source: The Financial Express
US President Donald Trump’s 100% tariff plan on patented drugs, generics remain exempt for now; here’s what it means for India's exports and future risks
